218 related articles for article (PubMed ID: 20423338)
21. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
Frau L; Simola N; Porceddu PF; Morelli M
Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954
[TBL] [Abstract][Full Text] [Related]
22. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
Rizzo FR; Federici M; Mercuri NB
Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
Taraska T; Finnegan KT
J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
[TBL] [Abstract][Full Text] [Related]
24. Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity.
Riezzo I; Cerretani D; Fiore C; Bello S; Centini F; D'Errico S; Fiaschi AI; Giorgi G; Neri M; Pomara C; Turillazzi E; Fineschi V
J Neurosci Res; 2010 Mar; 88(4):905-16. PubMed ID: 19798748
[TBL] [Abstract][Full Text] [Related]
25. d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity.
Johnson EA; Shvedova AA; Kisin E; O'Callaghan JP; Kommineni C; Miller DB
Brain Res; 2002 Apr; 933(2):150-63. PubMed ID: 11931860
[TBL] [Abstract][Full Text] [Related]
26. Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity.
Ke JJ; Ho MC; Cherng CG; Tsai YP; Tsai CW; Yu L
Chin J Physiol; 2008 Apr; 51(2):65-70. PubMed ID: 18666708
[TBL] [Abstract][Full Text] [Related]
27. DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).
Fornai F; Lenzi P; Frenzilli G; Gesi M; Ferrucci M; Lazzeri G; Biagioni F; Nigro M; Falleni A; Giusiani M; Pellegrini A; Blandini F; Ruggieri S; Paparelli A
Psychopharmacology (Berl); 2004 May; 173(3-4):353-63. PubMed ID: 14673567
[TBL] [Abstract][Full Text] [Related]
28. Adolescent exposure to MDMA induces dopaminergic toxicity in substantia nigra and potentiates the amyloid plaque deposition in the striatum of APPswe/PS1dE9 mice.
Abad S; Ramon C; Pubill D; Camarasa J; Camins A; Escubedo E
Biochim Biophys Acta; 2016 Sep; 1862(9):1815-26. PubMed ID: 27344237
[TBL] [Abstract][Full Text] [Related]
29. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2006 Sep; 51(4):885-95. PubMed ID: 16901518
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs.
Saadat KS; Elliott JM; Colado MI; Green AR
Psychopharmacology (Berl); 2004 May; 173(3-4):452-3. PubMed ID: 14663549
[No Abstract] [Full Text] [Related]
31. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
[TBL] [Abstract][Full Text] [Related]
32. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
33. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK
J Neurochem; 2001 Apr; 77(2):647-54. PubMed ID: 11299327
[TBL] [Abstract][Full Text] [Related]
35. Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes.
Barbosa DJ; Capela JP; Oliveira JM; Silva R; Ferreira LM; Siopa F; Branco PS; Fernandes E; Duarte JA; de Lourdes Bastos M; Carvalho F
Br J Pharmacol; 2012 Feb; 165(4b):1017-33. PubMed ID: 21506960
[TBL] [Abstract][Full Text] [Related]
36. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
[TBL] [Abstract][Full Text] [Related]
37. The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice.
Chitre NM; Bagwell MS; Murnane KS
Behav Brain Res; 2020 Feb; 380():112413. PubMed ID: 31809766
[TBL] [Abstract][Full Text] [Related]
38. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
40. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
